DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 1 filers reported holding DERMA SCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,975,000 | +24.3% | 1,148,970 | +11.7% | 0.20% | +30.6% |
| Q3 2016 | $4,805,000 | +21.8% | 1,028,920 | +2.8% | 0.16% | +9.0% |
| Q2 2016 | $3,945,000 | +23.7% | 1,001,360 | -2.6% | 0.14% | +24.1% |
| Q1 2016 | $3,188,000 | -28.7% | 1,028,460 | +5.1% | 0.12% | -24.7% |
| Q4 2015 | $4,471,000 | +87.9% | 978,318 | +93.7% | 0.15% | +108.1% |
| Q3 2015 | $2,379,000 | -37.8% | 505,150 | -5.5% | 0.07% | -31.5% |
| Q2 2015 | $3,827,000 | +82.6% | 534,450 | +115.9% | 0.11% | +80.0% |
| Q1 2015 | $2,096,000 | -31.6% | 247,520 | -24.8% | 0.06% | -32.6% |
| Q4 2014 | $3,065,000 | +2.6% | 329,202 | -8.2% | 0.09% | -3.3% |
| Q3 2014 | $2,987,000 | -28.4% | 358,579 | -0.7% | 0.09% | -24.6% |
| Q2 2014 | $4,174,000 | -22.8% | 361,072 | -15.3% | 0.12% | -16.4% |
| Q1 2014 | $5,405,000 | – | 426,250 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
| Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
| DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
| Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
| Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
| Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
| Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
| Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
| Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |